QUETIAPINE FUMARATE 50 mg/1 TABLET, EXTENDED RELEASE
Accord Healthcare Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Quetiapine Extended-release tablet is an atypical antipsychotic indicated for the treatment of: Schizophrenia (1.1) Bipolar I disorder, manic, or mixed episodes (1.2) Bipolar disorder, depressive episodes (1.2) Major depressive disorder, adjunctive therapy with antidepressants (1.3) 1.1 Schizophrenia Quetiapine Extended-release tablets are indicated for the treatment of schizophrenia. The efficacy of quetiapine extended-release tablets in schizophrenia was established in…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other QUETIAPINE FUMARATE NDC Codes
Wholesale and compliance resources
Order NDC 16729-0132-12 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).